In this issue:
Tamoxifen is ineffective in boys with Duchenne muscular dystrophy
Arimoclomol is ineffective in patients with inclusion body myositis
Extended- vs immediate-release carbidopa-levodopa for motor fluctuations in PD
Levetiracetam vs lamotrigine as first-line antiseizure medication in females
Association of brain atrophy with recovery after thrombectomy in stroke patients
Opicapone vs entacapone in patients with PD
Risk factors for neurological immune-related adverse events with ICIs
Neuropathological findings in brains of deceased young athletes exposed to repetitive head impacts
Isosorbide mononitrate + cilostazol in patients with cerebral small vessel disease
Consensus statement for the use of IVIg in neuromuscular disorders
Please login below to download this issue (PDF)